Viewing data from:

PARICALCITOL

ANDA

PARICALCITOL | A204948 | MARKSANS PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$2.45

per ea

Lowest NADAC/Unit

$1.17

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
49483068803PARICALCITOL 2 MCG CAPSULE	$2.45	EA	Generic	—	2026-06-17
49483068703PARICALCITOL 1 MCG CAPSULE	$1.17	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain10 active DMFs1 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

SAFC INCPARICALCITOL

DMF 113401995

TAPI NL BVPARICALCITOL USP

DMF 208652007

ALP PHARM BEIJING CO LTDPARICALCITOL USP (NON-STERILE DRUG SUBSTANCE)

DMF 212552008

FORMOSA LABORATORIES INCPARICALCITOL

DMF 218802008

NEULAND LABORATORIES LTDPARICALCITOL USP

DMF 238952010

ABBVIE INCPARICALCITOL DRUG SUBSTANCE

DMF 243152010

DISHMAN NETHERLANDS BVPARICALCITOL

DMF 253002011

SAI LIFE SCIENCES LTDPARICALCITOL USP, NON-STERILE BULK DRUG

DMF 265452012

CHONGQING HUAPONT PHARMACEUTICAL CO LTDPARICALCITOL

DMF 285502014

NANJING HERON PHARMACEUTICAL CO LTDPARICALCITOL

DMF 382692023

MICROBIOPHARM JAPAN CO LTDInactivePARICALCITOL, USP

DMF 271452013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 1MCG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Oct 7, 2016

No patent or exclusivity listings for this strength.

#002 — 2MCG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Oct 7, 2016

#003 — 4MCG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Oct 7, 2016